FindTrial
Sign In

Effect of takra and navaka guggulu on raised lipid levels.

To evaluate the add-on effect of takra sevan along with navaka guggulu in the management of hyperlipidemia a randomized controlled open labellled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/040982
Enrollment
60
Registered
2022-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with any of the borderline elevated lipid levels and low HDL levels. Patient willing to participate in study.

Exclusion criteria

Exclusion criteria: Chronicity for more than five years. Patient with cardiovascular disease and other severe conditions like asthma, Diabetes Mellitus, psychological disorders. Patient with allergic conditions like rhinitis and sinusitis. Pregnant women and lactating mother. Patient not able to consume drug on their own as in case of patients with paralysis.

Design outcomes

Primary

MeasureTime frame
Improvement in lipid profile of trial group will be evaluated at the end of 2months(60 days)Timepoint: 60 days—

Secondary

MeasureTime frame
Improvement in lipid profile of trial group will be evaluated at the end of study.Timepoint: 60 days(08 weeks)—

Countries

India

Contacts

Public ContactTANU DHAMA

All India Institute of Ayurveda

shivakumarsharti@gmail.com9611275434

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026